Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Salt and Water vs IV Saline for AKI Prevention in CKD
NCT02084771Phase 4Withdrawn
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium chloride in acute kidney injury (AKI), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Feasibility (recruitment rate, adherence to intervention and completeness of follow-up) at 24 months. Planned start Oct 2014; status: withdrawn.
02
Drugs
sodium chloride
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02084771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084771.